Manatee Memorial Hospital (MMH) has reached another milestone in structural heart procedures. According to Boston Scientific Corporation, Manatee Memorial ranks 8th in the country for total Watchman implants since 2015, out of more than 650 major medical centers in the United States. Atrial fibrillation (AF) is the most common cardiac arrhythmia, currently affecting up to seven million Americans.1  People with AF may be at greater risk for stroke than those with normal heart rhythms. The WATCHMAN FLX implant closes off an area of the heart called the left atrial appendage (LAA) to keep harmful blood clots that can form in the LAA from entering the blood stream and potentially causing a stroke. By closing off the LAA, the risk of stroke may be reduced and, over time, patients may be able to stop taking blood thinners. Watchman implanters are highly experienced and complete a detailed training program specific to the Watchman Implant. Leading the program is Medical Director Dr. Daniel Friedman, who has implanted more than half of all the implants at MMH since its inception. Dr. Jared Collins and Dr. Joseph Pace are also leading implanters who are approaching three hundred implants each. “I am thrilled to announce the success of our structural heart program at Manatee Memorial. This program has been providing innovative treatments, such as the Watchman device, to our patients for years. We are proud to serve Manatee County and its neighbors with high-quality care. Our team of experts is committed to improving and saving lives every day with mutual focus on excellence, innovation and compassion.” Tom McDougal, CEO of Manatee Memorial Hospital. On Tuesday February 20th and Saturday February 24th, the public is welcome to learn more about the Watchman implant when Dr. Friedman presents, “Atrial Fibrillation: No longer a lifetime of blood thinners.” Both presentations will be held at MMH’s main auditorium. RSVP to 941-708-8064.